|
|
There’s some great news in our sector that I’m excited to share with you this week!
|
|
I’d also like to congratulate another LSBC member and one of our award alums, Aurinia Pharmaceuticals. The company is a finalist in this year’s Scrip Awards under the Best New Drug - Non-COVID category for their Lupus nepthritis treatment, LUPKYNIS. You can see the shortlist reveal here and also watch here, when Aurinia won our own LSBC Deal of the Year award in September. The Scrip Awards will be presented during a ceremony in London, UK this December. All the best Aurinia!
In November, we’re holding our sixth annual Invest in BC, presented by Lumira Ventures. We now have over 250 investors from 31 countries registered to listen as 31 investor-ready BC life sciences companies present their pitches. I’m excited at how much interest there has been in this event, with the majority of investor interest registering before the companies were announced. As one of our investment- and innovation-focused signature events, I am proud to see that our LSBC programs and initiatives raise the life sciences profile at home and abroad. A big thank you to all our event sponsors, including Lumira Ventures, our presenting sponsor, and conference partner, adMare Bioinnovations. There’s a full list and registration link on the event website.
If you didn’t catch Wednesday’s webinar on IP and drug discovery, you can catch the recording here. Medicago’s Senior Supervisor in Intellectual Property, Isabelle Riedl described how the company managed IP protections for its plant-based biotherapeutics, while Sonia Ziesche, Principal and Patent Agent with event sponsor, Gowling WLG, noted that patents are for business planning too.
“Implement your IP strategy early on,” she advises.
Moderator, Brian Kingwell, who is a Partner with Gowling WLG summarized the whole IP discussion with advice to be active around IP strategy, noting that "a patent is not a patent is not a patent — they come in all sorts of flavours." Listen to the whole event on our YouTube channel.
Finally, Life Sciences BC was recognized this week in BC’s Legislature. Parliamentary Secretary for Technology and Innovation, Brenda Bailey, made remarks on increasing the representation of women in the tech sector during Private Members’ Motions. While pointing out the need to continue to focus on increasing diversity in our innovation sectors, MLA Bailey highlighted the following 25 female leaders. I am proud to be included on the list, alongside other female colleagues from our sector. Issues of equity, diversity, and inclusion are top of mind for LSBC, and we are focused on supporting our members in this area.
From MLA Bailey: “Here are 25 inspiring leaders for the young women interested in careers in tech to follow. In fact, if you're a mom or a dad, I encourage you to sit down at LinkedIn and follow these folks and point out to your children the extraordinary work that they are doing every day in our province. These are in no particular order. Veronique Lecault, who is the chief operating officer at AbCellera. Kristen Sutton is the chief technology and innovation officer at Vancity. Denise Williams, CEO at the First Nations Tech Council. Nerissa Allen, president at the Black Business Association of B.C. Jean Marie Owens, VP of operations at Phoenix Lab. Dr. Annette Rosik, chief science officer at Terramera. Jeanette Jackson, CEO at Foresight Cleantech Accelerator Centre. Alina Marley, CEO at Vancouver Economic Commission — congratulations on that change, Alina. Kim Caplin, a former executive at plenty of fish and now the founder and CEO at Snack. Stephanie Hollingshead, CEO of HR Tech Group, doing great work in diversity, equity and inclusion. Christy Wyatt, CEO at Absolute Software. Sue Paish, CEO at Canada's Digital Supercluster. Jill Tipping, CEO of the B.C. Tech Association. Dr. Alicia Maine, special adviser on innovation to the vice president of research at SFU. Angie Shick, executive director at New Ventures B.C. Wendy Hurlburt, president and CEO, Life Sciences B.C.”
-Wendy and the LSBC team
|
|
|
|
NervGen Pharma Corp., a clinical stage biotech company dedicated to creating innovative treatments for nervous system damage, provided a positive update on its Phase 1 program with NVG-291 in healthy volunteers at the 146th Annual Meeting of the American Neurological Association. READ MORE
|
|
|
|
Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, will present the Company’s latest data on its bioprinted pancreas therapeutic program at the International Pancreas and Islet Transplant Association Congress 2021, held virtually from October 20-23, 2021. READ MORE
|
|
|
|
Parliamentary Secretary for Technology and Innovation, Brenda Bailey, made remarks on increasing the representation of women in the tech sector, where LSBC President and CEO was mentioned. She made the comments during Private Members’ Motions, when MLAs discussed the contributions of women in traditionally male-dominated fields and workplace equality. READ MORE
|
|
|
|
We are publicly calling for new proposals related to drug development research as part our efforts for open innovation, to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes, and enterprises around the world. READ MORE
|
|
|
|
The DeepDyve Digital Library: a platform that is designed to make it easy and affordable for research organizations to discover, access, organize, and collaborate on peer-reviewed papers. But it’s an innovation that was nearly a decade in the making. READ MORE
|
|
 |
UBC is home to the only Faculty of Medicine in British Columbia; a world leader in health and biomedical research and a provincial hub for research that drives translational medicine. Within the UBC Faculty of Medicine, they saw an opportunity to develop a new, modern translational process, where drugs, therapeutics, devices, and diagnostics move through the development pipeline faster, more effectively, and more efficiently, thereby improving patient and population health and quality of life quickly, equitably, and sustainably. This opportunity has shaped the Academy of Translational Medicine as a new entity within the UBC Faculty of Medicine.
|
|
|
|
Metaphase Health Research Consulting Inc. provides medical and strategic writing services targeted at a specialist audience. They work with Health and Medical Research organizations, Pharmaceutical companies and Medical Communications companies. Please see www.metaphase-consulting.com for a description of their services and approach.
They are now working with DBS Medical Meeting Specialists to provide full medical meetings and event management services for virtual and hybrid events. See www.dbsmedicalmeetings.com for more details.
|
|
|
|
|
|
PERSPECTIVES ON GLOBAL HEALTHCARE INNOVATION |
What’s driving innovation in life science and healthcare? SVB is committed to serving the ecosystem by providing industry-leading reports featuring proprietary analysis and targeted outlooks to help companies and investors achieve their goals. Twice a year we publish deep-dive analyses describing fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank. To find out more about Silicon Valley Bank click here. |
|
This successful candidate for this role will be responsible for accounting, financial reporting, inventory management and will also support the HR function, along with other necessary tasks.
|
|
In this position you will manage activities with external vendors in support of manufacturing campaigns for the company's portfolio of drug candidates and much more.
|
|
You will be a valued member of a multidisciplinary R&D team focused on the development of cell-based implantable tissue therapeutics from discovery stage through scale up to clinical manufacturing.
|
|
|
|
Post A Job on the LSBC Website! |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish. After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? Contact Peter McLoughlin - talent@lifesciencesbc.ca
|
|
|
|
|
|
|
